BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37741968)

  • 41. Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia.
    Kneepkens E; Heijman E; Keupp J; Weiss S; Nicolay K; Grüll H
    Invest Radiol; 2017 Oct; 52(10):620-630. PubMed ID: 28598900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin.
    Bing C; Patel P; Staruch RM; Shaikh S; Nofiele J; Wodzak Staruch M; Szczepanski D; Williams NS; Laetsch T; Chopra R
    Int J Hyperthermia; 2019; 36(1):196-203. PubMed ID: 30541350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, open-label, randomised, controlled trial.
    Han F; Wang Y; Dong X; Lin Q; Wang Y; Gao W; Yun M; Li Y; Gao S; Huang H; Li N; Luo T; Luo X; Qiu M; Zhang D; Yan K; Li A; Liu Z
    Eur Radiol; 2024 Mar; 34(3):1481-1492. PubMed ID: 37796294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
    Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D
    BMC Cancer; 2021 Aug; 21(1):936. PubMed ID: 34412605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperthermia mediated liposomal drug delivery.
    Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
    Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.
    Zagar TM; Vujaskovic Z; Formenti S; Rugo H; Muggia F; O'Connor B; Myerson R; Stauffer P; Hsu IC; Diederich C; Straube W; Boss MK; Boico A; Craciunescu O; Maccarini P; Needham D; Borys N; Blackwell KL; Dewhirst MW
    Int J Hyperthermia; 2014 Aug; 30(5):285-94. PubMed ID: 25144817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo.
    Besse HC; Barten-van Rijbroek AD; van der Wurff-Jacobs KMG; Bos C; Moonen CTW; Deckers R
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31600958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy and hyperthermic release of doxorubicin from liposomal doxorubicin hydrochloride in rabbit VX2 tumours.
    Xiong P; Ding A; Su Z; Shen G; Chen Y; Zhang S
    Int J Hyperthermia; 2015; 31(8):900-8. PubMed ID: 26726929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic anti-tumour effects of local thermally sensitive liposome therapy.
    Viglianti BL; Dewhirst MW; Boruta RJ; Park JY; Landon C; Fontanella AN; Guo J; Manzoor A; Hofmann CL; Palmer GM
    Int J Hyperthermia; 2014 Sep; 30(6):385-92. PubMed ID: 25164143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin.
    de Smet M; Hijnen NM; Langereis S; Elevelt A; Heijman E; Dubois L; Lambin P; Grüll H
    Invest Radiol; 2013 Jun; 48(6):395-405. PubMed ID: 23399809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.
    Ponzini FM; Schultz CW; Leiby BE; Cannaday S; Yeo T; Posey J; Bowne WB; Yeo C; Brody JR; Lavu H; Nevler A
    BMJ Open; 2023 Oct; 13(10):e073839. PubMed ID: 37848297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.
    Partanen A; Yarmolenko PS; Viitala A; Appanaboyina S; Haemmerich D; Ranjan A; Jacobs G; Woods D; Enholm J; Wood BJ; Dreher MR
    Int J Hyperthermia; 2012; 28(4):320-36. PubMed ID: 22621734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
    Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic efficacy of the combination of doxorubicin-loaded liposomes with inertial cavitation generated by confocal ultrasound in AT2 Dunning rat tumour model.
    Mestas JL; Fowler RA; Evjen TJ; Somaglino L; Moussatov A; Ngo J; Chesnais S; Røgnvaldsson S; Fossheim SL; Nilssen EA; Lafon C
    J Drug Target; 2014 Sep; 22(8):688-97. PubMed ID: 24725154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma.
    Kotopoulis S; Stigen E; Popa M; Safont MM; Healey A; Kvåle S; Sontum P; Gjertsen BT; Gilja OH; McCormack E
    J Control Release; 2017 Jan; 245():70-80. PubMed ID: 27871988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies.
    Heinemann V; Reni M; Ychou M; Richel DJ; Macarulla T; Ducreux M
    Cancer Treat Rev; 2014 Feb; 40(1):118-28. PubMed ID: 23849556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
    Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
    Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy.
    Rezaeian M; Sedaghatkish A; Soltani M
    Drug Deliv; 2019 Dec; 26(1):898-917. PubMed ID: 31526065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.